Table 1—

Baseline characteristics (week 0) of the study population

INS + MET, add TGZINS + TGZ, add MET
n1414
Age (years)52.3 ± 10.554.7 ± 5.9
Sex (M/F)9/56/8
Ethnic group
 Caucasian89
 African American33
 Hispanic22
 Other10
Duration of diabetes (years)7.0 ± 4.013.0 ± 7.8*
Duration of INS therapy (years)2.7 ± 2.26.4 ± 4.8
Fasting C-peptide (ng/ml)3.1 ± 1.72.2 ± 1.0
Waist-to-hip ratio0.96 ± 0.080.93 ± 0.09
  • Data are means ± SD.

  • *

    * P < 0.03 vs. INS + MET group